Search Results for keywords:"AHRQ"

The Agency for Healthcare Research and Quality (AHRQ) is requesting the public to submit scientific information about interventional treatments for acute and chronic pain. This information is needed for a systematic review being done by AHRQ's Evidence-based Practice Centers Program. They are interested in studies related to these treatments, including those that cover adverse events. Submissions must be made by February 16, 2021, and should include study details such as methodology and outcomes, but not marketing or confidential information.

The Agency for Healthcare Research and Quality (AHRQ) is seeking public comments on developing measures for diagnostic excellence. This initiative aims to improve the diagnostic process in healthcare settings by using data from administrative sources or electronic health records. AHRQ is particularly interested in measures that could enhance patient safety, address diagnostic errors, and provide useful benchmarks for national surveillance. They welcome feedback on existing and potential measures that can be applied across various health systems and contribute to reducing health disparities.

The Agency for Healthcare Research and Quality (AHRQ) is seeking public input to develop measures for diagnostic excellence using data from administrative systems or electronic health records. These measures aim to identify opportunities to improve the diagnostic process on a large scale, helping to enhance healthcare quality and address diagnostic errors. AHRQ encourages feedback on the usefulness and importance of existing or new measures, especially those that are feasible, scientifically acceptable, and can identify gaps in diagnostic performance. Comments on this request must be submitted by February 13, 2025, to aid in shaping future healthcare policies and tools for better diagnostic practices.

The Agency for Healthcare Research and Quality (AHRQ) is requesting scientific information from the public to support its review of fusion procedures for degenerative lumbar spine disease, conducted by its Evidence-based Practice Centers Program. They are seeking both published and unpublished studies and data to enhance the quality of this review. The deadline for submissions is February 13, 2025, and interested parties can submit their contributions via email or regular mail. The draft review will be made available for public comment for four weeks once completed.

The Agency for Healthcare Research and Quality (AHRQ) is asking the public for scientific information to help with a review of medical care for adults with Down syndrome. This request is part of the Evidence-based Practice Centers (EPC) Program's efforts to gather relevant studies, both published and unpublished, to improve the quality of their review. The deadline for submissions is January 8, 2025, and contributions should include details about completed and ongoing studies, with appropriate documentation provided. The draft review will be available for public comment and will explore questions about the benefits and harms of various medical care practices for adults with Down syndrome.

The Agency for Healthcare Research and Quality (AHRQ), under the Department of Health and Human Services, announced five upcoming subcommittee meetings that will handle the review and discussion of grant applications. These meetings will be closed to the public to protect confidential information. The meetings are scheduled virtually on specific dates in February 2025, focusing on topics like healthcare safety, outcomes research, system value, research training, and information technology. For more details, interested parties can contact Jenny Griffith at AHRQ.

The Agency for Healthcare Research and Quality (AHRQ), part of the Health and Human Services Department (HHS), is holding a virtual public meeting of the National Advisory Council for Healthcare Research and Quality. Scheduled for March 18, 2021, from 10:00 a.m. to 2:00 p.m., the meeting will cover AHRQ's recent achievements in health systems research, communication, and strategies for advancing health equity. The meeting is open to the public, and details for attendance and participation can be found on the AHRQ website.

The Agency for Healthcare Research and Quality (AHRQ), part of the U.S. Department of Health and Human Services, announced five upcoming subcommittee meetings. These meetings are part of AHRQ's Health Services Research Initial Review Group Committee and will focus on reviewing and discussing grant applications. The meetings will cover various topics such as healthcare safety, effectiveness, system value, research training, and information technology. All meetings will be held virtually from February to early March 2021 and will be closed to the public to protect confidential information.

The Agency for Healthcare Research and Quality (AHRQ) is inviting public submissions of scientific information to support its review on preventing recurrent kidney stones in both adults and children. This review is conducted by AHRQ’s Evidence-based Practice Centers and aims to enhance the quality of evidence on the effectiveness and harms of preventive strategies, such as diet and medications. The deadline for submission is January 9, 2025, and interested parties are encouraged to submit completed and ongoing study information, ensuring the materials are publicly accessible. The review seeks to compare different preventive treatments and imaging strategies, as well as understand the natural progression of kidney stone recurrence.

The Agency for Healthcare Research and Quality (AHRQ) is seeking additional scientific information from the public to assist with a systematic review on managing menopausal symptoms in perimenopausal and early postmenopausal women. This review is being conducted by AHRQ's Evidence-based Practice Centers (EPC) Program to improve its quality by considering both published and unpublished relevant studies. People and organizations are invited to submit completed and ongoing study details, which should be public or able to be made public, by April 17, 2025. The review will explore questions related to the effectiveness and safety of treatments for menopausal symptoms, as well as individual and system-level factors influencing treatment.